Atocha M. Romero

Majadahonda, MD 28222, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications

PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups.

PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups.

Journal: medRxiv : the preprint server for health sciences
Published: July 29, 2026

Liquid Biopsy in Advanced Prostate Cancer.

Liquid Biopsy in Advanced Prostate Cancer.

Journal: Cancers
Published: March 31, 2026

Response.

Response.

Journal: Chest
Published: September 01, 2025

Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.

Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 29, 2025

Ni-Catalysts Supported on N,B-Doped Graphene Aerogels for CO2 Methanation.

Ni-Catalysts Supported on N,B-Doped Graphene Aerogels for CO2 Methanation.

Journal: ACS applied nano materials
Published: August 13, 2025

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial.

Journal: Nature communications
Published: May 23, 2025

Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensus.

Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensus.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 10, 2025

Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study.

Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 19, 2025

Optimized size exclusion chromatography demonstrates that extracellular vesicles are the key RNA carriers of ALK translocations in non-small cell lung cancer cell line secretome and patient plasma.

Optimized size exclusion chromatography demonstrates that extracellular vesicles are the key RNA carriers of ALK translocations in non-small cell lung cancer cell line secretome and patient plasma.

Journal: Extracellular vesicles and circulating nucleic acids
Published: February 03, 2025

A New Doped Graphene-Based Catalyst for Hydrogen Evolution Reaction Under Low-Electrolyte Concentration and Biomass-Rich Environments.

A New Doped Graphene-Based Catalyst for Hydrogen Evolution Reaction Under Low-Electrolyte Concentration and Biomass-Rich Environments.

Journal: Energy & fuels : an American Chemical Society journal
Published: December 12, 2024

KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories.

KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories.

Journal: Chest
Published: December 05, 2024

Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study.

Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study.

Journal: Translational lung cancer research
Published: October 07, 2024
Showing 1-12 of 170

Last Updated: 09/26/2026